Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| John Tagliamonte | M | 57 |
Mellitus LLC
 Mellitus LLC BiotechnologyHealth Technology Mellitus LLC develops vitro diagnostic tests for the measurement of Glycated CD59 (GCD59). Its vitro diagnostic test is also used for the stratification of complications risk and as a clinical trial test for pharmaceutical development. The company was founded by Jose Alberto Halperin, Joyce A. Lonergan and Michael Chorev in 2011 and is headquartered in Boston, MA. | - |
| Jose Halperin | M | - |
Mellitus LLC
Mellitus LLC BiotechnologyHealth Technology Mellitus LLC develops vitro diagnostic tests for the measurement of Glycated CD59 (GCD59). Its vitro diagnostic test is also used for the stratification of complications risk and as a clinical trial test for pharmaceutical development. The company was founded by Jose Alberto Halperin, Joyce A. Lonergan and Michael Chorev in 2011 and is headquartered in Boston, MA. | - |
| Michael Chorev | M | - |
Mellitus LLC
Mellitus LLC BiotechnologyHealth Technology Mellitus LLC develops vitro diagnostic tests for the measurement of Glycated CD59 (GCD59). Its vitro diagnostic test is also used for the stratification of complications risk and as a clinical trial test for pharmaceutical development. The company was founded by Jose Alberto Halperin, Joyce A. Lonergan and Michael Chorev in 2011 and is headquartered in Boston, MA. | - |
| Chris de Souza | M | - |
Mellitus LLC
Mellitus LLC BiotechnologyHealth Technology Mellitus LLC develops vitro diagnostic tests for the measurement of Glycated CD59 (GCD59). Its vitro diagnostic test is also used for the stratification of complications risk and as a clinical trial test for pharmaceutical development. The company was founded by Jose Alberto Halperin, Joyce A. Lonergan and Michael Chorev in 2011 and is headquartered in Boston, MA. | 7 ans |
| Xing Zhao | M | - |
Mellitus LLC
Mellitus LLC BiotechnologyHealth Technology Mellitus LLC develops vitro diagnostic tests for the measurement of Glycated CD59 (GCD59). Its vitro diagnostic test is also used for the stratification of complications risk and as a clinical trial test for pharmaceutical development. The company was founded by Jose Alberto Halperin, Joyce A. Lonergan and Michael Chorev in 2011 and is headquartered in Boston, MA. | - |
| Edwin Henrie | M | - |
Mellitus LLC
Mellitus LLC BiotechnologyHealth Technology Mellitus LLC develops vitro diagnostic tests for the measurement of Glycated CD59 (GCD59). Its vitro diagnostic test is also used for the stratification of complications risk and as a clinical trial test for pharmaceutical development. The company was founded by Jose Alberto Halperin, Joyce A. Lonergan and Michael Chorev in 2011 and is headquartered in Boston, MA. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 6 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
